Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
MACOM Technology Solutions Inc. announced a new portfolio of high-performance RF solutions designed to meet stringent aerospace and defense requirements. These include high-power amplifiers and front-end modules across S-Band, C-Band, X-Band, and wideband frequencies, incorporating GaN and GaAs technologies to enhance radar, communications, and ele…
We upgrade Mondelez to a buy for a swing trade. The company offers steady free cash flow, a 3.2% yield, and improving revenue momentum as cocoa prices ease — all while the shares sit below their 52-week high and technicals show room to run. Entry at $62.43, stop at $58.50 and targets at $67.00 and $71.15 for a mid-term (45 trading days) hold.
Xos, Inc., a US-based leader in electric commercial vehicles and energy storage systems, has announced a registered direct offering of approximately 1.1 million shares of common stock at $5.50 per share, intending to raise about $6 million in gross proceeds. The company plans to use the funds to expand its Power Hub and energy storage business targ…
Emergent BioSolutions Inc. supports National Naloxone Awareness Day through partnership with Victoria's Voice Foundation to promote opioid overdose education and expand access to NARCAN® Nasal Spray and KLOXXADO® Nasal Spray. The company highlights new initiatives including the NARCAN® Nasal Spray Carrying Case and upcoming outreach in colleges to …
Provident Bank announced the promotion of Annamaria Vitelli to Executive Vice President, Chief Wealth Officer of Provident Bank, and President of its wealth management subsidiary, Beacon Trust. Vitelli will lead strategic growth initiatives across Provident's wealth management business, collaborating with business divisions to enhance integrated fi…
Immutep Limited announced positive interim Phase I clinical trial results for IMP761, a first-in-class LAG-3 agonist antibody targeting autoimmune diseases. The single ascending dose study demonstrated favorable safety, tolerability, and significant pharmacodynamic activity at 7 mg/kg in healthy volunteers. These findings support further clinical d…
Arvinas, Inc. announced its participation in the Michael J. Fox Foundation-supported LRRK2 Investigative Therapeutics Exchange (LITE) and Parkinson’s Precision Medicine Initiative (PPMI) programs. This collaboration aims to advance ARV-102, an investigational PROTAC drug targeting LRRK2 for treating Parkinson’s disease and related neurodegenerative…
Diginex Limited announced an expansion of its supply chain product suite with Risk-to-Remedy, an integrated solution for supply chain transparency and labor rights compliance, designed to help businesses comply with tightening global human rights regulations. The enhancement combines technology for risk assessment, worker engagement, and grievance …
IMUNON, Inc. announced a structured financing deal raising up to $10 million to fund enrollment in its pivotal Phase 3 OVATION 3 trial of IMNN-001, a DNA-mediated immunotherapy for advanced ovarian cancer. The financing combines preferred stock issuance and secured promissory notes with favorable terms intended to minimize dilution. Recent Phase 2 …
LanzaTech Global, Inc. announced the IPO of its joint venture, Beijing Shougang LanzaTech Technology Co., Ltd., on the Hong Kong Stock Exchange. The JV raised approximately $75 million, achieving a market capitalization of around $750 million. LanzaTech retained an 8.38% stake post-IPO. The listing demonstrates commercial viability of LanzaTech's c…
VCI Global Limited (NASDAQ: VCIG) provided a strategic business update highlighting its expanding institutional investor base, which includes prominent players in digital assets and blockchain technology. The company is actively pursuing growth opportunities across artificial intelligence infrastructure, digital assets, real-world assets, and capit…
Amneal Pharmaceuticals announced FDA approval of its romidepsin injection solution, a ready-to-use formulation that simplifies hospital and pharmacy preparation compared to the previously marketed lyophilized powder. The product’s Competitive Generic Therapy designation grants Amneal 180 days of market exclusivity, enhancing its differentiated inje…
NextCure, Inc. announced the availability of a replay for its virtual Key Opinion Leader event discussing the first clinical efficacy data from the Phase 1 dose escalation study of SIM0505, an investigational antibody-drug conjugate targeting Cadherin-6, for ovarian and uterine serous carcinoma cancers. The event featured experts from leading cance…
ChronoScale Corporation announced the appointments of Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to accelerate the company's AI infrastructure platform growth and global compute solutions delivery. These leadership additions aim to strengthen innovation and scale operations to meet rising enterprise demand…
ARS Pharmaceuticals has announced a collaboration with former NFL star Drew Brees to raise awareness about severe food allergies and the importance of preparedness using neffy®, an FDA-approved needle-free epinephrine nasal spray. This partnership aims to educate patients and caregivers on prompt treatment of severe allergic reactions to prevent an…
Celularity Inc. and Fountain Life announce the availability of cenplacel-L, a placental-derived allogeneic cell therapy, for investigational use by licensed physicians in Florida under recently enacted state legislation. This new regulatory framework allows use of certain cell therapies without FDA approval, enabling physician-directed application …
Aya Gold & Silver Inc. released its 2025 Sustainability Report showcasing meaningful advancements in environmental management—such as reduced water and greenhouse gas intensities—robust social investments in local communities and employee training, and enhanced governance practices including ESG-linked executive incentives and increased female work…
Avalon GloboCare Corp., a NASDAQ-listed technology innovation company focused on consumer health and AI technology markets, appointed Sam Knipper as its new Chief Financial Officer effective June 1, 2026. Knipper brings extensive experience in financial reporting, SEC compliance, and strategic finance, particularly within emerging growth companies …
WW International, Inc. announces integration of its Weight Watchers Med+ program with Eli Lilly's digital healthcare platform, LillyDirect, to enhance nationwide patient access to GLP-1 prescription weight loss medications combined with behavioral and clinical support. This collaboration aims to provide a comprehensive and accessible approach to we…
IperionX Limited announced the Definitive Feasibility Study results for its 100%-owned Titan Critical Minerals Project in Tennessee. The DFS shows robust economics with an after-tax NPV8 of $813 million, a 39% IRR, and $1.9 billion in after-tax free cash flow over 14 years. The project will produce heavy rare earth concentrate, titanium minerals, a…
BIO-key International's Chairman and CEO will present at the RedChip Future Tech Investor Conference, highlighting the company's significant revenue growth and anticipated profitability in the first half of 2026. The company, a leader in biometric authentication and identity access management, expects 1H 2026 revenues to increase by 50% compared to…
Innio, the Munich-based maker of gas engines and distributed power systems, raised $2.43 billion in an upsized initial public offering and is due to begin trading in the U.S. later on Thursday. Backing from investors attracted to companies supplying the physical infrastructure for AI - particularly data-center power equipment - helped drive demand.…
HSBC is maintaining an aggressive allocation to risk assets but has been answering repeated client questions on what might trigger a shift to a bearish stance. Chief Multi-Asset Strategist Max Kettner says common concerns such as near-term U.S. earnings, geopolitics and front-end interest-rate moves rank low, while two higher-priority risks - broad…
A poll of foreign exchange analysts conducted May 29 to June 3 shows the Canadian dollar is expected to strengthen modestly against the U.S. dollar over the next year if Canada's economy stabilizes and there is headway in the review of the continental trade pact. Short-term gains hinge on resolution of trade uncertainties and an improvement in dome…
RBC Capital Markets has started coverage of Sylvania Platinum Ltd with an "outperform" rating and a 175 pence price target, implying roughly 106% upside from the current share price of 92 pence. The broker points to a robust free cash flow profile, a sum-of-the-parts adjusted NAV of $563 million (167p per share), and a key Thaba joint venture as pr…
